Emotional Brain is based in Almere, the Netherlands, and conducts fundamental scientific research into the causes of female sexual dysfunction and clinical research into treatment options. Two new on-demand drugs with blockbuster potential, Lybrido and Lybridos, are in development.
Moreover, Emotional Brain recently developed a novel method, based on genotyping using Single-Nucleotide Polymorphisms (SNPs) resulting in Phenotype Prediction Score (PPS) associated with traits and treatment effects. This innovative genetic method can be applied for the prediction whether someone is a responder or a non-responder to drug use (or traits). Other products are in early development stage. Over the years, Emotional Brain has published numerous well-cited papers in respected, peer-reviewed scientific journals such as Archives of General Psychiatry, the Journal of Sexual Medicine, Psychoneuroendocrinology and the British Journal of Clinical Pharmacology.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.